We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
+27.37%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$563M
AUM Growth
+$52.1M
Cap. Flow
-$54.1M
Cap. Flow %
-9.6%
Top 10 Hldgs %
49.74%
Holding
65
New
13
Increased
15
Reduced
18
Closed
8

Top Buys

Rank Stock Value
1
NUVA
NuVasive, Inc.
NUVA
+$7.38M
2
ACGN
Aceragen Inc
ACGN
+$6.67M
3
SPNC
Spectranetics Corp
SPNC
+$6.23M
4
TXMD icon
TherapeuticsMD
TXMD
+$5.15M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$4.96M

Top Sells

Rank Stock Value
1
NPSP
NPS PHARMACEUTICALS INC
NPSP
+$28.6M
2
IART icon
Integra LifeSciences
IART
+$11.1M
3
IPXL
Impax Laboratories, Inc.
IPXL
+$9.83M
4
ARTC
ARTHROCARE CORP
ARTC
+$9.17M
5
HITK
HI-TECH PHARMACAL INC
HITK
+$9.07M

Sector Composition

Rank Sector Weight
1 Healthcare 77.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CASM
51
DELISTED
CAS Medical Systems, Inc.
CASM
$1.74M 0.31%
1,300,896
+1,080,352
+490% +$1.59M
SQNM
52
DELISTED
SEQUENOM INC NEW
SQNM
$1.6M 0.28%
+600,000
New +$2.02M
CBST
53
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.59M 0.28%
+25,000
New +$1.51M
DGX icon
54
Quest Diagnostics
DGX
$25.1B
$1.54M 0.27%
+25,000
New +$1.5M
SGNT
55
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$1.39M 0.25%
+68,300
New +$1.52M
STRR
56
DELISTED
Star Equity Holdings
STRR
$460K 0.08%
+3,650
New +$465K
HNT
57
DELISTED
HEALTH NET INC
HNT
$63K 0.01%
+2,000
New +$63.1K
MMSI icon
58
Merit Medical Systems
MMSI
$4.43B
– –
-333,734
Closed -$3.72M
OSUR icon
59
OraSure Technologies
OSUR
$273M
– –
-500,000
Closed -$1.94M
RMTI icon
60
Rockwell Medical
RMTI
$26.2M
– –
-4,801
Closed -$1.91M
TEVA icon
61
CALL
Teva Pharmaceuticals
TEVA
$35.9B
– –
-3,000
Closed -$83K
INSY
62
DELISTED
Insys Therapeutics, Inc.
INSY
– –
-900,000
Closed -$4.15M
ARTC
63
DELISTED
ARTHROCARE CORP
ARTC
– –
-265,585
Closed -$9.17M
HITK
64
DELISTED
HI-TECH PHARMACAL INC
HITK
– –
-273,232
Closed -$9.07M
TSRX
65
DELISTED
TRIUS THERAPEUTICS INC COM STK (DE)
TSRX
– –
-404,427
Closed -$3.28M
1 2
3

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q3 2013 Portfolio in Review

As of Q3 2013, Broadfin Capital held 65 positions worth $563M, up 10% from $511M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Broadfin Capital withdrew a net $54.1M in Q3 2013, closing 8 positions and reducing 18 holdings. Its most notable exit was ARTHROCARE CORP, an estimated $9.17M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 73% a quarter earlier.

Against the trend, Broadfin Capital opened a new position in NuVasive, Inc. worth $7.35M.

  • Broadfin Capital's largest Q3 2013 buy was NuVasive, Inc.: 300,000 shares worth $7.35M.
  • Broadfin Capital added most to Spectranetics Corp in Q3 2013, an estimated $6.23M increase.
  • Broadfin Capital's biggest Q3 2013 reduction was NPS PHARMACEUTICALS INC, cutting an estimated $28.6M.
  • Broadfin Capital fully exited ARTHROCARE CORP in Q3 2013, selling an estimated $9.17M.
  • Broadfin Capital's ten largest holdings make up 50% of its $563M portfolio in Q3 2013.
  • Broadfin Capital opened 13 new positions and closed 8 in Q3 2013.
  • Broadfin Capital's portfolio value rose 10% quarter-over-quarter to $563M.

Based on Broadfin Capital's 13F filing for Q3 2013, filed 14 Nov 2013.